Toggle Offcanvas
...
 
Ranibizumab Tenders

Ranibizumab Tenders

View Ranibizumab tenders, RFPs and contracts. Bid on readily available Ranibizumab tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Ranibizumab tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Ranibizumab.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Ranibizumab market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Ranibizumab tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

34 Live Notices for Ranibizumab Tenders

Showing 1 to 20

Membekal Dan Menghantar Ubat Ranibizumab 10 Mg/Ml Inj (2.3Mg In 0.23Ml Vial) Ke Unit Farmasi Logistik, Jabatan Farmasi, Hospital Umum Sarawak Untuk Tempoh 18 Bulan (2025/Sf/080)
country Malaysia
posting date20 Jun 2025
deadline30 Jun 2025
Nhs National Framework For Medical Retinal Vascular Treatments - 1 December 2025
country United Kingdom
posting date19 Jun 2025
deadline04 Jul 2025
Framework Agreement Having The Purpose Of The Supply Of Ranibizumab (Atc S01La04)
country Belgium
posting date21 May 2025
deadline26 Jun 2025
Framework Agreement Having The Purpose Of The Supply Of Ranibizumab (Atc S01La04)
country Belgium
posting date21 May 2025
deadline26 Jun 2025
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts To The Active Ingredient Ranibizumab, As A Piercing Bottle, Atc S01La04
country Germany
posting date11 Apr 2025
deadline31 Mar 2027

Share Share this page